DEA Approves Study of Ecstasy for Anxiety Associated with Life-Threatening Illness

Ecstasy tablets.
Ecstasy tablets.

The Drug Enforcement Adminsitration (DEA) has approved a study of MDMA (pure ecstasy) for the treatment of anxiety associated with terminal illnesses.

“On March 13, 2015, the U.S. Drug Enforcement Administration approved the Schedule I license for Phil Wolfson, M.D., the Principal Investigator for our upcoming study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness”, the Multidisciplinary Association for Psychedelic Studies (MAPS) said in a recent newsletter. “This was the final regulatory approval needed for the study, which was approved by an Institutional Review Board (IRB) on September 16, 2014, the Research Advisory Panel of California (RAPC) on December 15, 2014, and by the U.S. Food and Drug Administration on November 13, 2014.”

Read moreDEA Approves Study of Ecstasy for Anxiety Associated with Life-Threatening Illness